Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2025 · fourth_quarter · Q4
H.R. 5371; Continuing Appropriations and Extension Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid S. 927; Protecting Pharmacies in Medicaid Act S. 882; Patients Before Middlemen Act S. 3345; PBM Price Transparency and Accountability Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 3389; Lowering Healthcare Costs for Americans Act S. 3264; More Affordable Care Act S. 3345; PBM Price Transparency and Accountability Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Source: Senate LDA
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Hidden Fee Disclosure Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Hidden Fee Disclosure Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
Hidden Fee Disclosure Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Hidden Fee Disclosure Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Hidden Fee Disclosure Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
DRUG Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
DRUG Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
DRUG Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
DRUG Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
DRUG Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 3389; Lowering Healthcare Costs for Americans Act S. 3264; More Affordable Care Act S. 3345; PBM Price Transparency and Accountability Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
DRUG Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Prescription Drug Transparency and Affordability Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act
Prescription Drug Transparency and Affordability Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Prescription Drug Transparency and Affordability Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Prescription Drug Transparency and Affordability Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
Prescription Drug Transparency and Affordability Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Prescription Drug Transparency and Affordability Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act
Prescription Drug Transparency and Affordability Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
Seniors’ Access to Critical Medications Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act
Seniors’ Access to Critical Medications Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
Seniors’ Access to Critical Medications Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
Seniors’ Access to Critical Medications Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act
Seniors’ Access to Critical Medications Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act
Seniors’ Access to Critical Medications Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act
Ensuring Community Access to Pharmacist Services Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
Ensuring Community Access to Pharmacist Services Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
Ensuring Community Access to Pharmacist Services Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Ensuring Community Access to Pharmacist Services Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act
Ensuring Community Access to Pharmacist Services Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 3389; Lowering Healthcare Costs for Americans Act S. 3264; More Affordable Care Act S. 3345; PBM Price Transparency and Accountability Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Ensuring Community Access to Pharmacist Services Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act
ETHIC Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
ETHIC Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
DTC Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
DTC Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act
DTC Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
Executive Order 14233 Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
PBM Reform Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 3389; Lowering Healthcare Costs for Americans Act S. 3264; More Affordable Care Act S. 3345; PBM Price Transparency and Accountability Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
PBM Reform Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
PBM Reform Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
PBM Reform Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act
PBM Reform Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 5371; Continuing Appropriations and Extension Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid S. 927; Protecting Pharmacies in Medicaid Act S. 882; Patients Before Middlemen Act S. 3345; PBM Price Transparency and Accountability Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
PBM Reform Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act
Fair Pharmacies for Federal Employees Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act
Fair Pharmacies for Federal Employees Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
Fair Pharmacies for Federal Employees Act of 2025
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act
Plain Prescription Prices Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
Plain Prescription Prices Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 3389; Lowering Healthcare Costs for Americans Act S. 3264; More Affordable Care Act S. 3345; PBM Price Transparency and Accountability Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 5371; Continuing Appropriations and Extension Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid S. 927; Protecting Pharmacies in Medicaid Act S. 882; Patients Before Middlemen Act S. 3345; PBM Price Transparency and Accountability Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act
Patients Deserve Price Tags Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
Patients Deserve Price Tags Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act
Pharmacists Fight Back in Medicare and Medicaid Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 5371; Continuing Appropriations and Extension Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid S. 927; Protecting Pharmacies in Medicaid Act S. 882; Patients Before Middlemen Act S. 3345; PBM Price Transparency and Accountability Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Pharmacists Fight Back in Medicare and Medicaid Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 3389; Lowering Healthcare Costs for Americans Act S. 3264; More Affordable Care Act S. 3345; PBM Price Transparency and Accountability Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 3389; Lowering Healthcare Costs for Americans Act S. 3264; More Affordable Care Act S. 3345; PBM Price Transparency and Accountability Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Saving Seniors Money on Prescriptions Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Saving Seniors Money on Prescriptions Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Saving Seniors Money on Prescriptions Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Drug Competition Enhancement Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Drug Competition Enhancement Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Drug Competition Enhancement Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
Drug Competition Enhancement Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
Drug Competition Enhancement Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Affordable Prescriptions for Patients Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Affordable Prescriptions for Patients Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
Affordable Prescriptions for Patients Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
Affordable Prescriptions for Patients Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Affordable Prescriptions for Patients Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Stop STALLING Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
Stop STALLING Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Stop STALLING Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
Stop STALLING Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Stop STALLING Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Increasing Transparency in Generic Drug Applications Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Increasing Transparency in Generic Drug Applications Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
Increasing Transparency in Generic Drug Applications Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Increasing Transparency in Generic Drug Applications Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Expedited Access to Biosimilars Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
Expedited Access to Biosimilars Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
Restore Prescription Drugs Discount Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act
Restore Prescription Drugs Discount Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
Restore Prescription Drugs Discount Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
Restore Prescription Drugs Discount Act
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · Firm: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act
H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2025 · third_quarter · Q3
H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act H.R. 3798/ S. 229; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 5371; Continuing Appropriations and Extension Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act S.2276; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act H.R. 2484; Seniors Access to Critical Medications Act S.229/H.R.3789, the Drug Price Transparency for Consumers Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act H.R. 4623; Plain Prescription Prices Act S. 2620; Reforming Evergreening and Manipulation that Extends Drug Years
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 5371; Continuing Appropriations and Extension Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 5582/S. 2355; Patients Deserve Price Tags Act H.R. 4317; PBM Reform Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2025 · second_quarter · Q2
H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 882; Patients Before Middlemen Act H.R. 2484; Seniors Access to Critical Medications Act
S. 1041; Affordable Prescriptions for Patients Act S. 1040; Drug Competition Enhancement Act S. 229; Drug-price Transparency for Consumers Act H.R. 3789; Drug-price Transparency for Consumers Act S. 1414; Expedited Access to Biosimilars Act S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 3269; Eliminating Thickets to Increase Competition Act H.R. 2214; Delinking Revenue from Unfair Gouging Act S.864: Help Ensure Lower Patients (HELP) Copays Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 832/ H.R. 1492; Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041; Affordable Prescriptions for Patients Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2041; Hidden Fee Disclosure Act S.1095; Stop the STALLING Act S. 1302; Increasing Transparency in Generic Drug Application Act H.R. 2484; Seniors Access to Critical Medications Act
S. 2099; Restore Prescription Drug Discount Act H.R. 1; One Big Beautiful Bill Act oAs engrossed in House 5/22/25 oSec. 44123. Ensuring accurate payments to pharmacies under Medicaid. oSec. 44124. Preventing the use of abusive spread pricing in Medicaid. oSec. 44305. Modernizing and Ensuring PBM Accountability. H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2450; Prescription Drug Transparency and Affordability Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act S. 526; Pharmacy Benefit Manager Transparency Act S. 527; Prescription Pricing for the People Act H.R. 2484; Seniors Access to Critical Medications Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2025 · first_quarter · Q1
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2024 · fourth_quarter · Q4
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits H.R.10545- December Continuing Resolution H.R.9096- Pharmacists Fight Back Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits H.R.10545- December Continuing Resolution H.R.9096- Pharmacists Fight Back Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy H.R.10545 - December Continuing Resolution H.R. 9096 - Pharmacists Fight Back Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2024 · third_quarter · Q3
Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.652 - Safe Step Act S.775 - Increasing Transparency in Generic Drug Applications Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1339 - Pharmacy Benefit Manager Reform Act S.1542/H.R.6283 - Delinking Revenue from Unfair Gouging (DRUG) Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act S.150 - Affordable Prescriptions for Patients Act of 2023 H.R.1352 - Increasing Access to Biosimilars Act H.R.1790 - Biologics Competition Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R. 8261- Preserving Telehealth, Hospital, and Ambulance Access Act, Sec. 302 H.R.7623- Telehealth Modernization Act of 2024 H.R.4758- Accelerating Kids Access to Care Act AINS Sec. 3 H.R.9096- Pharmacists Fight Back Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2024 · second_quarter · Q2
Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.652 - Safe Step Act S.775 - Increasing Transparency in Generic Drug Applications Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1339 - Pharmacy Benefit Manager Reform Act S.1542/H.R.6283 - Delinking Revenue from Unfair Gouging (DRUG) Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act S.150 - Affordable Prescriptions for Patients Act of 2023 H.R.1352 - Increasing Access to Biosimilars Act H.R.1790 - Biologics Competition Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R. 8261- Preserving Telehealth, Hospital, and Ambulance Access Act, Sec. 302 H.R.7623- Telehealth Modernization Act of 2024 H.R.4758 - Accelerating Kids Access to Care Act AINS Sec. 3 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2024 · first_quarter · Q1
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1339 - Pharmacy Benefit Manager Reform Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4507 - Transparency in Coverage Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4883 - Medicare Common Ownership Transparency Act H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2023 · fourth_quarter · Q4
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2023 · third_quarter · Q3
Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.150 - Affordable Prescriptions for Patients Act S.652 - Safe Step Act S.655 - Chronic Disease Management Act S.727 - Insulin for All Act S.775 - Increasing Transparency in Generic Drug Applications Act S.954 - Affordable Insulin Now Act S.1038 - Drug Price Transparency in Medicaid Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1218 - Fair Prescription Drug Prices for Americans Act S.1269 - INSULIN Act S.1339 - Pharmacy Benefit Manager Reform Act S.1375 - HELP Copays Act S.1497 - Emergency Access to Insulin Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1542 - Delinking Revenue from Unfair Gouging (DRUG) Act S.1543 - A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third party administration services S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1488 - Affordable Insulin Now Act H.R.1587 - Making Insulin Affordable for All Children Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.1790 - Biologics Competition Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3030 - Stop the Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act H.R.3134 - Emergency Access to Insulin Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.3800 - Chronic Disease Flexible Coverage Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4507 - Transparency in Coverage Act H.R.4508 - Hidden Fee Disclosure Act H.R.4509 - Transparency in Billing Act H.R.4527 - Health Data Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4846 - To amend the Internal Revenue Code of 1986, title XXVII of the Public Health Service Act, and the Employee Retirement Income Security Act of 1974 to provide for oversight of pharmacy benefit manager services H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2023 · second_quarter · Q2
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits H.R.2666 -- Medicaid MVP for Patients Act S.652 / H.R.2630 -- Safe Step Act H.R.2679 -- Pharmacy Benefits Manager Accountability Act H.R.2691 - Transparent PRICE Act H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications Act H.R.3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.4011 - Timely Access to Clinical Treatment Act S.1038 / H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacist Services Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S. 1375 / H.R.830 - Help Ensure Lower Patient (HELP) Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.3799 - CHOICE Arrangement Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act H.R.3284 - Providers and Payers COMPETE Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2023 · first_quarter · Q1
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.127 - A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes S. 1038 / H.R.1613 - To amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program S.1131 - A bill to amend title XI of the Social Security Act and title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits H.R.1770 - To amend title XVIII of the Social Security Act to provide pharmacy payment of certain services CMS-4201-P RIN 0938-AU96: Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2022 · fourth_quarter · Q4
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2355: Opioid Prescription Verification Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524: Health Care PRICE Transparency Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act S.2164: Lower Costs More Cures Act H.R.3554: To amend title XVIII of the Social Security Act to reform requirements with respect to direct and indirect remuneration under Medicare part D, and for other purposes H.R.6851: To amend the Families First Coronavirus Response Act and the CARES Act to establish new coverage and payment rules for certain COVID-19 diagnostic tests and related items and services, and for other purposes S.4293: Pharmacy Benefit Manager Transparency Act 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees 42 CFR Parts 422 423 RIN 0938-AU30 Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P)
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2022 · third_quarter · Q3
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 S.464 / H.R.2163: Safe Step Act S.917: Short on Competition Act H.R.2355: Opioid Prescription Verification Act H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2843: STOP GAMES Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2853: BLOCKING Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1425 / H.R.2883: Stop STALLING Act S.1427 / H.R.2869: Increasing Access to Biosimilars Act S.1428 / H.R.2891: Preserve Access to Affordable Generics and Biosimilars Act S.1435 / H.R.2873: Affordable Prescriptions for Patients Act of 2021 / Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S.1462: Simplifying the Generic Drug Application Process Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524 / H.R.3029: Health Care PRICE Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs More Cures Act H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program H.R.4502: Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022 H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act H.R.4813: Matts Act S.2814: Vital Medication Affordability Act S.1132: Ending Pricey Insulin (EPI) Act H.R.3062: A bill making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for fiscal year ending September 30, 2022 H.R.6000: The CURES 2.0 Act, To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes H.R.3554: To amend title XVIII of the Social Security Act to reform requirements with respect to direct and indirect remuneration under Medicare part D, and for other purposes H.R.6851: To amend the Families First Coronavirus Response Act and the CARES Act to establish new coverage and payment rules for certain COVID-19 diagnostic tests and related items and services, and for other purposes S.3700: A bill to provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans H.R.6833: To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes H.R.6757: To amend title XVIII of the Social Security Act to establish under the Medicare prescription drug program a minimum amount of price concessions for insulin to be passed through to beneficiaries at the point-of-sale, and for other purposes H.R.7008: To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers, and for other purposes H.R.7047: To amend title III of the Public Health Service Act with respect to the determination by the Secretary regarding certain biosimilar application elements, and for other purposes H.R.6833: Affordable Insulin Now Act H.R.6963: Accelerated Approval Integrity Act H.R.7008: Pre-approval Information Exchange Act H.R.7032: Increasing Transparency in Generic Drug Applications Act H.R.7047: Lowering Costs by Improving Biosimilar Uptake Act S.4011: Capping Drug Costs for Seniors Act of 2022 H.R.7666: Restoring Hope for Mental Health and Well-Being Act H.R.7667: Food and Drug Amendments of 2022 H.R.7828: To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 5 years; (PRICED Act) S.4293: Pharmacy Benefit Manager Transparency Act S.4348: A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes; (FDASLA Act) H.R.7995: GOLD CARD Act H.R.5376: The Inflation Reduction Act, Sec. 139301, Prohibiting implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees 42 CFR Parts 422 423 RIN 0938-AU30 Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P)
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2022 · second_quarter · Q2
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 S.464 / H.R.2163: Safe Step Act S.917: Short on Competition Act H.R.2355: Opioid Prescription Verification Act H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2843: STOP GAMES Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2853: BLOCKING Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1425 / H.R.2883: Stop STALLING Act S.1427 / H.R.2869: Increasing Access to Biosimilars Act S.1428 / H.R.2891: Preserve Access to Affordable Generics and Biosimilars Act S.1435 / H.R.2873: Affordable Prescriptions for Patients Act of 2021 / Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S.1462: Simplifying the Generic Drug Application Process Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524 / H.R.3029: Health Care PRICE Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs More Cures Act H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program H.R.4502: Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022 H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act H.R.4813: Matts Act S.2814: Vital Medication Affordability Act S.1132: Ending Pricey Insulin (EPI) Act H.R.3062: A bill making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for fiscal year ending September 30, 2022 H.R.6000: The CURES 2.0 Act, To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes H.R.3554: To amend title XVIII of the Social Security Act to reform requirements with respect to direct and indirect remuneration under Medicare part D, and for other purposes H.R.6851: To amend the Families First Coronavirus Response Act and the CARES Act to establish new coverage and payment rules for certain COVID-19 diagnostic tests and related items and services, and for other purposes S.3700: A bill to provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans H.R.6833: To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes H.R.6757: To amend title XVIII of the Social Security Act to establish under the Medicare prescription drug program a minimum amount of price concessions for insulin to be passed through to beneficiaries at the point-of-sale, and for other purposes H.R.7008: To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers, and for other purposes H.R.7047: To amend title III of the Public Health Service Act with respect to the determination by the Secretary regarding certain biosimilar application elements, and for other purposes H.R.6833: Affordable Insulin Now Act H.R.6963: Accelerated Approval Integrity Act H.R.7008: Pre-approval Information Exchange Act H.R.7032: Increasing Transparency in Generic Drug Applications Act H.R.7047: Lowering Costs by Improving Biosimilar Uptake Act S.4011: Capping Drug Costs for Seniors Act of 2022 H.R.7666: Restoring Hope for Mental Health and Well-Being Act H.R.7667: Food and Drug Amendments of 2022 H.R.7828: To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 5 years; (PRICED Act) S.4293: Pharmacy Benefit Manager Transparency Act S.4348: A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes; (FDASLA Act) H.R.7995: GOLD CARD Act 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees 42 CFR Parts 422 423 RIN 0938-AU30 Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P)
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2022 · first_quarter · Q1
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2855: Star Ratings for Biosimilars Act S.1523: The Drug Price Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs, More Cures Act of 2021 H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program H.R.2815: BIOSIM Act S.464 / H.R.2163: Safe Step Act S.1524 / H.R.3029: Health Care PRICE Transparency Act H.R.4418: SPIKE Act H.R.5237: A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes. H.R.5260: Reduced Costs and Continued Cures Act H.R.3684: The Infrastructure Investment and Jobs Act, Sec.90006, Moratorium on implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates H.R.5376: The Build Back Better Act, Sec. 139301, Prohibiting implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates H.R.5623: The Insulin Cost Reduction Act, To amend title XVIII of the Social Security Act to prohibit price concessions with respect to insulin drugs and exceptions under Part D of Medicare, and for other purposes H.R.3554: To amend title XVIII of the Social Security Act to reform requirements with respect to direct and indirect remuneration under Medicare part D, and for other purposes S.3700: A bill to provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans H.R.6833: To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes H.R.6757: To amend title XVIII of the Social Security Act to establish under the Medicare prescription drug program a minimum amount of price concessions for insulin to be passed through to beneficiaries at the point-of-sale, and for other purposes 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees 42 CFR Parts 422 423 RIN 0938-AU30 Medicare Program; Contract Year 2003 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P)
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2021 · fourth_quarter · Q4
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2855: Star Ratings for Biosimilars Act S.1523: The Drug Price Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs, More Cures Act of 2021 H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program H.R.2815: BIOSIM Act S.464 / H.R.2163: Safe Step Act S.1524 / H.R.3029: Health Care PRICE Transparency Act H.R.4418: SPIKE Act H.R.5237: A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes. H.R.5260: Reduced Costs and Continued Cures Act H.R.3684: The Infrastructure Investment and Jobs Act, Sec.90006, Moratorium on implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates H.R.5376: The Build Back Better Act, Sec. 139301, Prohibiting implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates H.R.5623: The Insulin Cost Reduction Act, To amend title XVIII of the Social Security Act to prohibit price concessions with respect to insulin drugs and exceptions under Part D of Medicare, and for other purposes 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2021 · third_quarter · Q3
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2355: Opioid Prescription Verification Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524: Health Care PRICE Transparency Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act S.2164: Lower Costs More Cures Act 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2021 · second_quarter · Q2
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 S.464 / H.R.2163: Safe Step Act S.917: Short on Competition Act H.R.2355: Opioid Prescription Verification Act H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2843: STOP GAMES Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2853: BLOCKING Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1425 / H.R.2883: Stop STALLING Act S.1427 / H.R.2869: Increasing Access to Biosimilars Act S.1428 / H.R.2891: Preserve Access to Affordable Generics and Biosimilars Act S.1435 / H.R.2873: Affordable Prescriptions for Patients Act / Affordable Prescriptions for Patients Through Promoting Competition Act H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S.1462: Simplifying the Generic Drug Application Process Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524: Health Care PRICE Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs More Cures Act H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2021 · first_quarter · Q1
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy Access to prescription drugs during the coronavirus pandemic 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits Access to prescription drugs during the coronavirus pandemic 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2020 · fourth_quarter · Q4
Issues related to the use of the United States Postal Service (USPS) for prescription drug home delivery H.R.8123/S.4174: Postal Service Emergency Assistance Act H.R.133: Consolidated Appropriations Act, 2021
Issues related to prescription drug coverage and pharmacy benefits H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1035: Prescription Drug Price Transparency Act H.R.5800: Ban Surprise Billing Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits H.R.19/S.3129: Lower Costs More Cures Act H.R.2279/S.2546: Safe Step Act H.R.3: Lower Drug Costs Now Act H.R. 6557 MAIL Act S.3384: Lowering Prescription Drug Prices for America's Seniors and Families Act S.3013: Encouraging Innovative Benefit Design to Lower Costs for Seniors Act Executive Order on An America-First Healthcare Plan Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees Prescription drug pricing transparency H.R.1264/S.801: Payment Commission Data Act H.R.223/S.532: PBM Study Act H.R.1781: Payment Commission Data Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.5304: PBM Transparency in Prescription Drug Costs Act H.R.133: Consolidated Appropriations Act, 2021 S.476: C-THRU Act S.2543: Prescription Drug Pricing Reduction Act Access to prescription drugs during the coronavirus pandemic H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6557: MAIL Act H.R.6800: HEROES Act Generic and biosimilar utilization H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2020 · third_quarter · Q3
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1035: Prescription Drug Price Transparency Act H.R.5800: Ban Surprise Billing Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act S.1895: Lower Health Care Costs Act Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy Prescription drug pricing transparency H.R.2376/S.1227: Prescription Pricing for the People Act H.R.3223/S.1532: PBM Study Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.5304: PBM Transparency in Prescription Drug Costs Act S.476: C-THRU Act S.2543: Prescription Drug Pricing Reduction Act S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act Regulatory and proposed legislative changes to Medicare Part D H.R.19/S.3129: Lower Costs More Cures Act H.R.3: Lower Drug Costs Now Act S.3013: Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S.3384: Lowering Prescription Drug Prices for America's Seniors and Families Act Executive Order on An America-First Healthcare Plan Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen Access to prescription drugs during the coronavirus pandemic H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6557: MAIL Act H.R.6800: HEROES Act Generic and biosimilar utilization H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes (McKinley) Issues related to coverage of prescription drugs in the commercial market S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act S.1895: Lower Health Care Costs Act H.R.5304: PBM Transparency in Prescription Drug Costs Act H.R.5800: Ban Surprise Billing Act
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2020 · second_quarter · Q2
Issues related to prescription drug coverage and pharmacy benefits H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1035: Prescription Drug Price Transparency Act H.R.5800: Ban Surprise Billing Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act S.1895: Lower Health Care Costs Act Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market Prescription drug pricing transparency H.R.1264/S.801: Payment Commission Data Act H.R.2376/S.1227: Prescription Pricing for the People Act H.R.3223/S.1532 PBM Study Act H.R.1781: Payment Commission Data Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.5304: PBM Transparency in Prescription Drug Costs Act S.476: C-THRU Act S.2543: Prescription Drug Pricing Reduction Act S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits H.R.19/S.3129:Lower Costs More Cures Act H.R.2279/S.2546: Safe Step Act H.R.6557: MAIL Act H.R.3: Lower Drug Costs Now Act S.3013: Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S.3384: Lowering Prescription Drug Prices for America's Seniors and Families Act Access to prescription drugs during the coronavirus pandemic H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6557 MAIL Act H.R.6800: HEROES Act Generic and biosimilar utilization H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes (McKinley) Issues related to prescription drug patents and approval process H.R.938: Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act H.R.985: Fair Access for Safe and Timely (FAST) Generics Act H.R.1499: Protecting Consumer Access to Generic Drugs Act H.R.1520: Purple Book Continuity Act H.R.1503: Orange Book Transparency Act S.64: Preserve Access to Affordable Generics and Biosimilars Act S.659: Biologic Patent Transparency Act Issues related to coverage of prescription drugs in the commercial market S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act S.1895: Lower Health Care Costs Act H.R.5304: PBM Transparency in Prescription Drug Costs Act H.R.5800: Ban Surprise Billing Act
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2020 · first_quarter · Q1
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.2376/S.1227: Prescription Pricing for the People Act H.R.19/S.3129: Lower Costs More Cures Act H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.1035: Prescription Drug Price Transparency Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.3: Lower Drug Costs Now Act H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes H.R.5304: PBM Transparency in Prescription Drug Costs Act H.R.5800: Ban Surprise Billing Act S.476: C-THRU Act S.977: Transparent Drug Pricing Act S.1895: Lower Health Care Costs Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act S.3130: Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S.3384: Lowering Prescription Drug Prices for America's Seniors and Families Act
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2019 · fourth_quarter · Q4
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.2376/S.1227: Prescription Pricing for the People Act H.R.1035: Prescription Drug Price Transparency Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.3: Lower Drug Costs Now Act H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes S.476: C-THRU Act S.977: Transparent Drug Pricing Act S.1895: Lower Health Care Costs Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2019 · third_quarter · Q3
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits Issues related to HHS OIG Proposed Rule 42 CFR Part 1001 RIN 0936-AA08; Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1264/S.801: Payment Commission Data Act H.R.1035: Prescription Drug Price Transparency Act H.R.1781: Payment Commission Data Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.3: Lower Drug Costs Now Act S.476: C-THRU Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2019 · second_quarter · Q2
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy Issues related to HHS OIG Proposed Rule 42 CFR Part 1001 RIN 0936-AA08; Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees Issues related to CMS Proposed Rule 42 CFR Parts 422 and 423 RIN 0938-AT92; Modernizing Part D and Medicare Advantage To Lower Out-of-Pocket Expenses H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.2376/S.1227: Prescription Pricing for the People Act S.476: C-THRU Act S.977: Transparent Drug Pricing Act S.1895: Lower Health Care Costs Act H.R.1035: Prescription Drug Price Transparency Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION via PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2019 · first_quarter · Q1
Issues related to prescription drug coverage and pharmacy benefits. Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits. Issues included in the Administrations drug pricing Blueprint. Issues related to HHS OIG Proposed Rule 42 CFR Part 1001 RIN 0936-AA08; Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees Issues related to CMS Proposed Rule 42 CFR Parts 422 and 423 RIN 0938-AT92; Modernizing Part D and Medicare Advantage To Lower Out-of-Pocket Expenses H.R. 803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R.1034/S.640: Phair Pricing Act of 2019. H.R.1035: Prescription Drug Price Transparency Act. S. 476: C-THRU Act S.801/H.R. 1264: Payment Commission Data Act
Issues related to prescription drug coverage and pharmacy benefits. Issues included in the Administrations drug pricing Blueprint. Issues related to HHS OIG Proposed Rule 42 CFR Part 1001 RIN 0936-AA08; Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Proposed Rule 42 CFR Parts 422 and 423 RIN 0938-AT92; Modernizing Part D and Medicare Advantage To Lower Out-of-Pocket Expenses. Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market. Issues related to the affordability of prescription drugs and competitive marketplace, including: pedigree, manufacturer market and data exclusivity, REMS, accelerated generic approval, biosimilars. H.R. 803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R.1034/S.640: Phair Pricing Act of 2019. H.R.1035: Prescription Drug Price Transparency Act. S. 476: C-THRU Act S.801/H.R. 1264: Payment Commission Data Act S. 64: Preserve Access to Affordable Generics and Biosimilars Act H.R. 938: Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act S. 340/H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act H.R. 985: Fair Access for Safe and Timely (FAST) Generics Act S 659: Biologic Patent Transparency Act H.R.1499: Protecting Consumer Access to Generic Drugs Act H.R.1520: Purple Book Continuity Act H.R. 1503: Orange Book Transparency Act
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R. 8261- Preserving Telehealth, Hospital, and Ambulance Access Act, Sec. 302 H.R.7623- Telehealth Modernization Act of 2024 H.R.4758- Accelerating Kids Access to Care Act AINS Sec. 3 H.R.9096- Pharmacists Fight Back Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.1339 - Pharmacy Benefit Manager Reform Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act S.1542/H.R.6283 - Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 8261- Preserving Telehealth, Hospital, and Ambulance Access Act, Sec. 302 H.R.7623- Telehealth Modernization Act of 2024 H.R.4758 - Accelerating Kids Access to Care Act AINS Sec. 3 H.R. 9096 - Pharmacists Fight Back Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R. 8261- Preserving Telehealth, Hospital, and Ambulance Access Act, Sec. 302 H.R.7623- Telehealth Modernization Act of 2024 H.R.4758- Accelerating Kids Access to Care Act AINS Sec. 3 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.1339 - Pharmacy Benefit Manager Reform Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act S.1542/H.R.6283 - Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 8261- Preserving Telehealth, Hospital, and Ambulance Access Act, Sec. 302 H.R.7623- Telehealth Modernization Act of 2024 H.R.4758 - Accelerating Kids Access to Care Act AINS Sec. 3 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.150 - Affordable Prescriptions for Patients Act S.652 - Safe Step Act S.655 - Chronic Disease Management Act S.727 - Insulin for All Act S.775 - Increasing Transparency in Generic Drug Applications Act S.954 - Affordable Insulin Now Act S.1038 - Drug Price Transparency in Medicaid Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1218 - Fair Prescription Drug Prices for Americans Act S.1269 - INSULIN Act S.1339 - Pharmacy Benefit Manager Reform Act S.1375 - HELP Copays Act S.1497 - Emergency Access to Insulin Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1542 - Delinking Revenue from Unfair Gouging (DRUG) Act S.1543 - A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third party administration services S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1488 - Affordable Insulin Now Act H.R.1587 - Making Insulin Affordable for All Children Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.1790 - Biologics Competition Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3030 - Stop the Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act H.R.3134 - Emergency Access to Insulin Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.3800 - Chronic Disease Flexible Coverage Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4507 - Transparency in Coverage Act H.R.4508 - Hidden Fee Disclosure Act H.R.4509 - Transparency in Billing Act H.R.4527 - Health Data Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4846 - To amend the Internal Revenue Code of 1986, title XXVII of the Public Health Service Act, and the Employee Retirement Income Security Act of 1974 to provide for oversight of pharmacy benefit manager services H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1339 - Pharmacy Benefit Manager Reform Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4507 - Transparency in Coverage Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4883 - Medicare Common Ownership Transparency Act H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.150 - Affordable Prescriptions for Patients Act S.652 - Safe Step Act S.655 - Chronic Disease Management Act S.727 - Insulin for All Act S.775 - Increasing Transparency in Generic Drug Applications Act S.954 - Affordable Insulin Now Act S.1038 - Drug Price Transparency in Medicaid Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1218 - Fair Prescription Drug Prices for Americans Act S.1269 - INSULIN Act S.1339 - Pharmacy Benefit Manager Reform Act S.1375 - HELP Copays Act S.1497 - Emergency Access to Insulin Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1542 - Delinking Revenue from Unfair Gouging (DRUG) Act S.1543 - A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third party administration services S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1488 - Affordable Insulin Now Act H.R.1587 - Making Insulin Affordable for All Children Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.1790 - Biologics Competition Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3030 - Stop the Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act H.R.3134 - Emergency Access to Insulin Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.3800 - Chronic Disease Flexible Coverage Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4507 - Transparency in Coverage Act H.R.4508 - Hidden Fee Disclosure Act H.R.4509 - Transparency in Billing Act H.R.4527 - Health Data Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4846 - To amend the Internal Revenue Code of 1986, title XXVII of the Public Health Service Act, and the Employee Retirement Income Security Act of 1974 to provide for oversight of pharmacy benefit manager services H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1339 - Pharmacy Benefit Manager Reform Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4507 - Transparency in Coverage Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4883 - Medicare Common Ownership Transparency Act H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act H.R.2679 - Pharmacy Benefits Manager Accountability Act H.R.2691 - Transparent PRICE Act H.R.3281 - Transparent PRICE Act S.1339 - Pharmacy Benefit Manager Reform Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.1038 / H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacist Services Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act H.R.3284 - Providers and Payers COMPETE Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration
Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act H.R.2666 - Medicaid MVP for Patients Act S.652 / H.R.2630 - Safe Step Act H.R.2679 - Pharmacy Benefits Manager Accountability Act H.R.2691 - Transparent PRICE Act H.R.3281 - Transparent PRICE Act S.1339 - Pharmacy Benefit Manager Reform Act S.1543 - A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third party administration services H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications Act H.R.3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.4011 - Timely Access to Clinical Treatment Act S.1038 / H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacist Services Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S. 1375 / H.R.830 - Help Ensure Lower Patient (HELP) Copays Act S.954 / H.R.1488 - Affordable Insulin Now Act H.R.1503 - Prescription Information Modernization Act H.R.1352 - Increasing Access to Biosimilars Act S.1374 - Patient Right to Shop Act H.R.3799 - CHOICE Arrangement Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.150 - Affordable Prescriptions for Patients Act S.574 - Increasing Prescription Drug Competition Act S.775 - Increasing Transparency in Generic Drug Applications Act H.R.1790 - Biologics Competition Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1522 - A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act H.R.3284 - Providers and Payers COMPETE Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes S.127 - A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes S. 1038 / H.R.1613 - To amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program H.R.1770 - To amend title XVIII of the Social Security Act to provide pharmacy payment of certain services CMS-4201-P RIN 0938-AU96: Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications
Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes S.127 - A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes S.142 - A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products S.148 - A bill to enable to Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes S.150 - A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S.574 - A bill to amend the Federal Food, Drug, and Cosmetic Act to prevent the use of patents, trade secrets, or other intellectual property to inhibit competition S.652 - A bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes S.727/H.R.1485 - A bill to limit the price charged by manufacturers for insulin S.775 - A bill to provide for increased transparency in generic drug applications S.954 - A bill to provide for appropriate cost-sharing for insulin products covered under private health plans, and to establish a program to support health care providers and pharmacies in providing discounted insulin products to uninsured individuals S. 1038 / H.R.1613 - To amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program S.1067 - A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions S.1114 - A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period S.1120 - A bill to improve the actions available to eligible product developers in the event of delays in receiving covered product for purposes of generic drug or biosimilar biological product development S.1128 - A bill to establish special rules relating to information provided with respect to drug applications concerning method of use patents S.1131 - A bill to amend title XI of the Social Security Act and title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits H.R.830 - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R.1485 - To limit the price charged by manufacturers for insulin H.R.1488 - To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes H.R.1770 - To amend title XVIII of the Social Security Act to provide pharmacy payment of certain services CMS-4201-P RIN 0938-AU96: Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2855: Star Ratings for Biosimilars Act S.1523: The Drug Price Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs, More Cures Act of 2021 H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program H.R.2815: BIOSIM Act S.464 / H.R.2163: Safe Step Act S.1524 / H.R.3029: Health Care PRICE Transparency Act H.R.4418: SPIKE Act H.R.5237: A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes. H.R.5260: Reduced Costs and Continued Cures Act H.R.3684: The Infrastructure Investment and Jobs Act, Sec.90006, Moratorium on implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates H.R.5376: The Build Back Better Act, Sec. 139301, Prohibiting implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates H.R.5376: The Inflation Reduction Act, Sec. 139301, Prohibiting implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates H.R.5623: The Insulin Cost Reduction Act, To amend title XVIII of the Social Security Act to prohibit price concessions with respect to insulin drugs and exceptions under Part D of Medicare, and for other purposes H.R.3554: To amend title XVIII of the Social Security Act to reform requirements with respect to direct and indirect remuneration under Medicare part D, and for other purposes S.3700: A bill to provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans H.R.6833: To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes H.R.6757: To amend title XVIII of the Social Security Act to establish under the Medicare prescription drug program a minimum amount of price concessions for insulin to be passed through to beneficiaries at the point-of-sale, and for other purposes H.R.6833: Affordable Insulin Now Act S.4011: Capping Drug Costs for Seniors Act of 2022 H.R.7995: GOLD CARD Act 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees 42 CFR Parts 422 423 RIN 0938-AU30 Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P)
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 S.464 / H.R.2163: Safe Step Act S.917: Short on Competition Act H.R.2355: Opioid Prescription Verification Act H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2843: STOP GAMES Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2853: BLOCKING Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1425 / H.R.2883: Stop STALLING Act S.1427 / H.R.2869: Increasing Access to Biosimilars Act S.1428 / H.R.2891: Preserve Access to Affordable Generics and Biosimilars Act S.1435 / H.R.2873: Affordable Prescriptions for Patients Act of 2021 / Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S.1462: Simplifying the Generic Drug Application Process Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524 / H.R.3029: Health Care PRICE Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs More Cures Act H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program H.R.4502: Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022 H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act H.R.4813: Matts Act S.2814: Vital Medication Affordability Act S.1132: Ending Pricey Insulin (EPI) Act H.R.3062: A bill making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for fiscal year ending September 30, 2022 H.R.6000: The CURES 2.0 Act, To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes H.R.3554: To amend title XVIII of the Social Security Act to reform requirements with respect to direct and indirect remuneration under Medicare part D, and for other purposes H.R.6851: To amend the Families First Coronavirus Response Act and the CARES Act to establish new coverage and payment rules for certain COVID-19 diagnostic tests and related items and services, and for other purposes S.3700: A bill to provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans H.R.6833: To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes H.R.6757: To amend title XVIII of the Social Security Act to establish under the Medicare prescription drug program a minimum amount of price concessions for insulin to be passed through to beneficiaries at the point-of-sale, and for other purposes H.R.7008: To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers, and for other purposes H.R.7047: To amend title III of the Public Health Service Act with respect to the determination by the Secretary regarding certain biosimilar application elements, and for other purposes H.R.6833: Affordable Insulin Now Act H.R.6963: Accelerated Approval Integrity Act H.R.7008: Pre-approval Information Exchange Act H.R.7032: Increasing Transparency in Generic Drug Applications Act H.R.7047: Lowering Costs by Improving Biosimilar Uptake Act S.4011: Capping Drug Costs for Seniors Act of 2022 H.R.7666: Restoring Hope for Mental Health and Well-Being Act H.R.7667: Food and Drug Amendments of 2022 H.R.7828: To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 5 years; (PRICED Act) S.4293: Pharmacy Benefit Manager Transparency Act S.4348: A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes; (FDASLA Act) H.R.7995: GOLD CARD Act H.R.5376: The Inflation Reduction Act, Sec. 139301, Prohibiting implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees 42 CFR Parts 422 423 RIN 0938-AU30 Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2355: Opioid Prescription Verification Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524: Health Care PRICE Transparency Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act S.2164: Lower Costs More Cures Act H.R.3554: To amend title XVIII of the Social Security Act to reform requirements with respect to direct and indirect remuneration under Medicare part D, and for other purposes H.R.6851: To amend the Families First Coronavirus Response Act and the CARES Act to establish new coverage and payment rules for certain COVID-19 diagnostic tests and related items and services, and for other purposes S.4293: Pharmacy Benefit Manager Transparency Act 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees 42 CFR Parts 422 423 RIN 0938-AU30 Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P)
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2855: Star Ratings for Biosimilars Act S.1523: The Drug Price Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs, More Cures Act of 2021 H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program H.R.2815: BIOSIM Act S.464 / H.R.2163: Safe Step Act S.1524 / H.R.3029: Health Care PRICE Transparency Act H.R.4418: SPIKE Act H.R.5237: A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes. H.R.5260: Reduced Costs and Continued Cures Act H.R.3684: The Infrastructure Investment and Jobs Act, Sec.90006, Moratorium on implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates H.R.5376: The Build Back Better Act, Sec. 139301, Prohibiting implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates H.R.5376: The Inflation Reduction Act, Sec. 139301, Prohibiting implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates H.R.5623: The Insulin Cost Reduction Act, To amend title XVIII of the Social Security Act to prohibit price concessions with respect to insulin drugs and exceptions under Part D of Medicare, and for other purposes H.R.3554: To amend title XVIII of the Social Security Act to reform requirements with respect to direct and indirect remuneration under Medicare part D, and for other purposes S.3700: A bill to provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans H.R.6833: To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes H.R.6757: To amend title XVIII of the Social Security Act to establish under the Medicare prescription drug program a minimum amount of price concessions for insulin to be passed through to beneficiaries at the point-of-sale, and for other purposes H.R.6833: Affordable Insulin Now Act S.4011: Capping Drug Costs for Seniors Act of 2022 H.R.7995: GOLD CARD Act 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees 42 CFR Parts 422 423 RIN 0938-AU30 Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2855: Star Ratings for Biosimilars Act S.1523: The Drug Price Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs, More Cures Act of 2021 H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program H.R.2815: BIOSIM Act S.464 / H.R.2163: Safe Step Act S.1524 / H.R.3029: Health Care PRICE Transparency Act H.R.4418: SPIKE Act H.R.5237: A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes. H.R.5260: Reduced Costs and Continued Cures Act H.R.3684: The Infrastructure Investment and Jobs Act, Sec.90006, Moratorium on implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates H.R.5376: The Build Back Better Act, Sec. 139301, Prohibiting implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates H.R.5623: The Insulin Cost Reduction Act, To amend title XVIII of the Social Security Act to prohibit price concessions with respect to insulin drugs and exceptions under Part D of Medicare, and for other purposes H.R.3554: To amend title XVIII of the Social Security Act to reform requirements with respect to direct and indirect remuneration under Medicare part D, and for other purposes S.3700: A bill to provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans H.R.6833: To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes H.R.6757: To amend title XVIII of the Social Security Act to establish under the Medicare prescription drug program a minimum amount of price concessions for insulin to be passed through to beneficiaries at the point-of-sale, and for other purposes H.R.6833: Affordable Insulin Now Act S.4011: Capping Drug Costs for Seniors Act of 2022 H.R.799: GOLD CARD Act 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees 42 CFR Parts 422 423 RIN 0938-AU30 Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P)
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2355: Opioid Prescription Verification Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524: Health Care PRICE Transparency Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act S.2164: Lower Costs More Cures Act H.R.3554: To amend title XVIII of the Social Security Act to reform requirements with respect to direct and indirect remuneration under Medicare part D, and for other purposes H.R.6851: To amend the Families First Coronavirus Response Act and the CARES Act to establish new coverage and payment rules for certain COVID-19 diagnostic tests and related items and services, and for other purposes S.4293: Pharmacy Benefit Manager Transparency Act 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees 42 CFR Parts 422 423 RIN 0938-AU30 Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 S.464 / H.R.2163: Safe Step Act S.917: Short on Competition Act H.R.2355: Opioid Prescription Verification Act H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2843: STOP GAMES Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2853: BLOCKING Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1425 / H.R.2883: Stop STALLING Act S.1427 / H.R.2869: Increasing Access to Biosimilars Act S.1428 / H.R.2891: Preserve Access to Affordable Generics and Biosimilars Act S.1435 / H.R.2873: Affordable Prescriptions for Patients Act of 2021 / Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S.1462: Simplifying the Generic Drug Application Process Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524 / H.R.3029: Health Care PRICE Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs More Cures Act H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program H.R.4502: Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022 H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act H.R.4813: Matts Act S.2814: Vital Medication Affordability Act S.1132: Ending Pricey Insulin (EPI) Act H.R.3062: A bill making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for fiscal year ending September 30, 2022 H.R.6000: The CURES 2.0 Act, To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes H.R.3554: To amend title XVIII of the Social Security Act to reform requirements with respect to direct and indirect remuneration under Medicare part D, and for other purposes H.R.6851: To amend the Families First Coronavirus Response Act and the CARES Act to establish new coverage and payment rules for certain COVID-19 diagnostic tests and related items and services, and for other purposes S.3700: A bill to provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans H.R.6833: To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes H.R.6757: To amend title XVIII of the Social Security Act to establish under the Medicare prescription drug program a minimum amount of price concessions for insulin to be passed through to beneficiaries at the point-of-sale, and for other purposes H.R.7008: To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers, and for other purposes H.R.7047: To amend title III of the Public Health Service Act with respect to the determination by the Secretary regarding certain biosimilar application elements, and for other purposes 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees 42 CFR Parts 422 423 RIN 0938-AU30 Medicare Program; Contract Year 2003 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P)
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2355: Opioid Prescription Verification Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524: Health Care PRICE Transparency Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act S.2164: Lower Costs More Cures Act H.R.3554: To amend title XVIII of the Social Security Act to reform requirements with respect to direct and indirect remuneration under Medicare part D, and for other purposes H.R.6851: To amend the Families First Coronavirus Response Act and the CARES Act to establish new coverage and payment rules for certain COVID-19 diagnostic tests and related items and services, and for other purposes 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees 42 CFR Parts 422 423 RIN 0938-AU30 Medicare Program; Contract Year 2003 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2355: Opioid Prescription Verification Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524: Health Care PRICE Transparency Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act S.2164: Lower Costs More Cures Act 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 S.464 / H.R.2163: Safe Step Act S.917: Short on Competition Act H.R.2355: Opioid Prescription Verification Act H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2843: STOP GAMES Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2853: BLOCKING Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1425 / H.R.2883: Stop STALLING Act S.1427 / H.R.2869: Increasing Access to Biosimilars Act S.1428 / H.R.2891: Preserve Access to Affordable Generics and Biosimilars Act S.1435 / H.R.2873: Affordable Prescriptions for Patients Act of 2021 / Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S.1462: Simplifying the Generic Drug Application Process Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524 / H.R.3029: Health Care PRICE Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs More Cures Act H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program H.R.4502: Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022 H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act H.R.4813: Matts Act S.2814: Vital Medication Affordability Act S.1132: Ending Pricey Insulin (EPI) Act H.R.3062: A bill making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for fiscal year ending September 30, 2022 H.R.6000: The CURES 2.0 Act, To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2855: Star Ratings for Biosimilars Act S.1523: The Drug Price Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs, More Cures Act of 2021 H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program H.R.2815: BIOSIM Act S.464 / H.R.2163: Safe Step Act S.1524 / H.R.3029: Health Care PRICE Transparency Act H.R.4418: SPIKE Act H.R.5237: A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes. H.R.5260: Reduced Costs and Continued Cures Act H.R.3684: The Infrastructure Investment and Jobs Act, Sec.90006, Moratorium on implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates H.R.5376: The Build Back Better Act, Sec. 139301, Prohibiting implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 S.464 / H.R.2163: Safe Step Act S.917: Short on Competition Act H.R.2355: Opioid Prescription Verification Act H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2843: STOP GAMES Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2853: BLOCKING Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1425 / H.R.2883: Stop STALLING Act S.1427 / H.R.2869: Increasing Access to Biosimilars Act S.1428 / H.R.2891: Preserve Access to Affordable Generics and Biosimilars Act S.1435 / H.R.2873: Affordable Prescriptions for Patients Act of 2021 / Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S.1462: Simplifying the Generic Drug Application Process Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524 / H.R.3029: Health Care PRICE Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs More Cures Act H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program H.R.4502: Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022 H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act H.R.4813: Matts Act S.2814: Vital Medication Affordability Act S.1132: Ending Pricey Insulin (EPI) Act 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2355: Opioid Prescription Verification Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524: Health Care PRICE Transparency Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act S.2164: Lower Costs More Cures Act 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2855: Star Ratings for Biosimilars Act S.1523: The Drug Price Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs, More Cures Act of 2021 H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits Access to prescription drugs during the coronavirus pandemic 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to prescription drug coverage and pharmacy benefits H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1035: Prescription Drug Price Transparency Act H.R.5800: Ban Surprise Billing Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act S.1895: Lower Health Care Costs Act Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market Prescription drug pricing transparency H.R.1264/S.801: Payment Commission Data Act H.R.2376/S.1227: Prescription Pricing for the People Act H.R.3223/S.1532 PBM Study Act H.R.1781: Payment Commission Data Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.5304: PBM Transparency in Prescription Drug Costs Act H.R.133: Consolidated Appropriations Act, 2021 S.476: C-THRU Act S.2543: Prescription Drug Pricing Reduction Act S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits H.R.19/S.3129:Lower Costs More Cures Act H.R.2279/S.2546: Safe Step Act H.R.6557: MAIL Act H.R.3: Lower Drug Costs Now Act S.3013: Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S.3384: Lowering Prescription Drug Prices for America's Seniors and Families Act Executive Order on An America-First Healthcare Plan Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees Access to prescription drugs during the coronavirus pandemic H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6557 MAIL Act H.R.6800: HEROES Act Generic and biosimilar utilization H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes (McKinley) Issues related to prescription drug patents and approval process H.R.938: Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act H.R.985: Fair Access for Safe and Timely (FAST) Generics Act H.R.1499: Protecting Consumer Access to Generic Drugs Act H.R.1520: Purple Book Continuity Act H.R.1503: Orange Book Transparency Act S.64: Preserve Access to Affordable Generics and Biosimilars Act S.659: Biologic Patent Transparency Act Issues related to coverage of prescription drugs in the commercial market H.R.5304: PBM Transparency in Prescription Drug Costs Act H.R.5800: Ban Surprise Billing Act S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act S.1895: Lower Health Care Costs Act
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1035: Prescription Drug Price Transparency Act H.R.5800: Ban Surprise Billing Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act S.1895: Lower Health Care Costs Act Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy Prescription drug pricing transparency H.R.2376/S.1227: Prescription Pricing for the People Act H.R.3223/S.1532: PBM Study Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.5304: PBM Transparency in Prescription Drug Costs Act H.R.133: Consolidated Appropriations Act, 2021 S.476: C-THRU Act S.2543: Prescription Drug Pricing Reduction Act S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act Regulatory and proposed legislative changes to Medicare Part D H.R.19/S.3129: Lower Costs More Cures Act H.R.3: Lower Drug Costs Now Act S.3013: Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S.3384: Lowering Prescription Drug Prices for America's Seniors and Families Act Executive Order on An America-First Healthcare Plan Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees Access to prescription drugs during the coronavirus pandemic H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6557: MAIL Act H.R.6800: HEROES Act Generic and biosimilar utilization H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes (McKinley) Issues related to coverage of prescription drugs in the commercial market H.R.5304: PBM Transparency in Prescription Drug Costs Act H.R.5800: Ban Surprise Billing Act S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act S.1895: Lower Health Care Costs Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to the use of the United States Postal Service (USPS) for prescription drug home delivery H.R.8123/S.4174: Postal Service Emergency Assistance Act
Issues related to prescription drug coverage and pharmacy benefits H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1035: Prescription Drug Price Transparency Act H.R.5800: Ban Surprise Billing Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act S.1895: Lower Health Care Costs Act Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market Prescription drug pricing transparency H.R.1264/S.801: Payment Commission Data Act H.R.2376/S.1227: Prescription Pricing for the People Act H.R.3223/S.1532 PBM Study Act H.R.1781: Payment Commission Data Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.5304: PBM Transparency in Prescription Drug Costs Act S.476: C-THRU Act S.2543: Prescription Drug Pricing Reduction Act S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits H.R.19/S.3129:Lower Costs More Cures Act H.R.2279/S.2546: Safe Step Act H.R.6557: MAIL Act H.R.3: Lower Drug Costs Now Act S.3013: Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S.3384: Lowering Prescription Drug Prices for America's Seniors and Families Act Executive Order on An America-First Healthcare Plan Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen Access to prescription drugs during the coronavirus pandemic H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6557 MAIL Act H.R.6800: HEROES Act Generic and biosimilar utilization H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes (McKinley) Issues related to prescription drug patents and approval process H.R.938: Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act H.R.985: Fair Access for Safe and Timely (FAST) Generics Act H.R.1499: Protecting Consumer Access to Generic Drugs Act H.R.1520: Purple Book Continuity Act H.R.1503: Orange Book Transparency Act S.64: Preserve Access to Affordable Generics and Biosimilars Act S.659: Biologic Patent Transparency Act Issues related to coverage of prescription drugs in the commercial market S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act S.1895: Lower Health Care Costs Act H.R.5304: PBM Transparency in Prescription Drug Costs Act H.R.5800: Ban Surprise Billing Act
Issues related to prescription drug coverage and pharmacy benefits H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1035: Prescription Drug Price Transparency Act H.R.5800: Ban Surprise Billing Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits H.R.19/S.3129: Lower Costs More Cures Act H.R. 2279/S.2546: Safe Step Act H.R.3: Lower Drug Costs Now Act H.R. 6557 MAIL Act S.3384: Lowering Prescription Drug Prices for America's Seniors and Families Act S.3013: Encouraging Innovative Benefit Design to Lower Costs for Seniors Act Executive Order on An America-First Healthcare Plan Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen Prescription drug pricing transparency H.R.1264/S.801: Payment Commission Data Act H.R.223/S.532: PBM Study Act H.R.1781: Payment Commission Data Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.5304: PBM Transparency in Prescription Drug Costs Act S.476: C-THRU Act S.2543: Prescription Drug Pricing Reduction Act Access to prescription drugs during the coronavirus pandemic H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6557: MAIL Act H.R.6800: HEROES Act Generic and biosimilar utilization H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to the use of the United States Postal Service (USPS) for prescription drug home delivery
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1035: Prescription Drug Price Transparency Act H.R.5800: Ban Surprise Billing Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act S.1895: Lower Health Care Costs Act Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy Prescription drug pricing transparency H.R.2376/S.1227: Prescription Pricing for the People Act H.R.3223/S.1532: PBM Study Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.5304: PBM Transparency in Prescription Drug Costs Act S.476: C-THRU Act S.2543: Prescription Drug Pricing Reduction Act S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act Regulatory and proposed legislative changes to Medicare Part D H.R.19/S.3129: Lower Costs More Cures Act H.R.3: Lower Drug Costs Now Act S.3013: Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S.3384: Lowering Prescription Drug Prices for America's Seniors and Families Act Access to prescription drugs during the coronavirus pandemic H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6557: MAIL Act H.R.6800: HEROES Act Generic and biosimilar utilization H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes (McKinley) Issues related to coverage of prescription drugs in the commercial market S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act S.1895: Lower Health Care Costs Act H.R.5304: PBM Transparency in Prescription Drug Costs Act H.R.5800: Ban Surprise Billing Act
Issues related to prescription drug coverage and pharmacy benefits H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1035: Prescription Drug Price Transparency Act H.R.5800: Ban Surprise Billing Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits H.R.19/S.3129: Lower Costs More Cures Act H.R. 2279/S.2546: Safe Step Act H.R.3: Lower Drug Costs Now Act H.R. 6557 MAIL Act S.3384: Lowering Prescription Drug Prices for America's Seniors and Families Act S.3013: Encouraging Innovative Benefit Design to Lower Costs for Seniors Act Prescription drug pricing transparency H.R.1264/S.801: Payment Commission Data Act H.R.223/S.532: PBM Study Act H.R.1781: Payment Commission Data Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.5304: PBM Transparency in Prescription Drug Costs Act S.476: C-THRU Act S.2543: Prescription Drug Pricing Reduction Act Access to prescription drugs during the coronavirus pandemic H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6557: MAIL Act H.R.6800: HEROES Act Generic and biosimilar utilization H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to prescription drug coverage and pharmacy benefits Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market Issues related to the affordability of prescription drugs and competitive marketplace, including: pedigree, manufacturer market and data exclusivity, REMS, accelerated generic approval, biosimilars H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1264/S.801: Payment Commission Data Act H.R.965/S.340: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act H.R.2376/S.1227: Prescription Pricing for the People Act H.R. 19/S.3129: Lower Costs More Cures Act H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.1035: Prescription Drug Price Transparency Act H.R.938: Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act H.R.985: Fair Access for Safe and Timely (FAST) Generics Act H.R.1499: Protecting Consumer Access to Generic Drugs Act H.R.1520: Purple Book Continuity Act H.R.1503: Orange Book Transparency Act H.R.1781: Payment Commission Data Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.3: Lower Drug Costs Now Act H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes H.R.5304: PBM Transparency in Prescription Drug Costs Act H.R.5800: Ban Surprise Billing Act S.476: C-THRU Act S.64: Preserve Access to Affordable Generics and Biosimilars Act S.659: Biologic Patent Transparency Act S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act S.1895: Lower Health Care Costs Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act S.3130: Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S.3384: Lowering Prescription Drug Prices for America's Seniors and Families Act
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1264/S.801: Payment Commission Data Act H.R.19/S.3129: Lower Costs More Cures Act H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.1035: Prescription Drug Price Transparency Act H.R.1781: Payment Commission Data Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.3: Lower Drug Costs Now Act H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes H.R.5304: PBM Transparency in Prescription Drug Costs Act H.R.5800: Ban Surprise Billing Act S.476: C-THRU Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act S.3130: Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S.3384: Lowering Prescription Drug Prices for America's Seniors and Families Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1264/S.801: Payment Commission Data Act H.R.1035: Prescription Drug Price Transparency Act H.R.1781: Payment Commission Data Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.3: Lower Drug Costs Now Act H.R. 4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes S.476: C-THRU Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act
Issues related to prescription drug coverage and pharmacy benefits Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market Issues related to the affordability of prescription drugs and competitive marketplace, including: pedigree, manufacturer market and data exclusivity, REMS, accelerated generic approval, biosimilars H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1264/S.801: Payment Commission Data Act H.R.965/S.340: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act H.R.2376/S.1227: Prescription Pricing for the People Act H.R.1035: Prescription Drug Price Transparency Act H.R.938: Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act H.R.985: Fair Access for Safe and Timely (FAST) Generics Act H.R.1499: Protecting Consumer Access to Generic Drugs Act H.R.1520: Purple Book Continuity Act H.R.1503: Orange Book Transparency Act H.R.1781: Payment Commission Data Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.3: Lower Drug Costs Now Act H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes S.476: C-THRU Act S.64: Preserve Access to Affordable Generics and Biosimilars Act S.659: Biologic Patent Transparency Act S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act S.1895: Lower Health Care Costs Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy Issues related to HHS OIG Proposed Rule 42 CFR Part 1001 RIN 0936-AA08; Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.2376/S.1227: Prescription Pricing for the People Act H.R.1035: Prescription Drug Price Transparency Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.3: Lower Drug Costs Now Act S.476: C-THRU Act S.977: Transparent Drug Pricing Act S.1895: Lower Health Care Costs Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act
Issues related to prescription drug coverage and pharmacy benefits Issues related to HHS OIG Proposed Rule 42 CFR Part 1001 RIN 0936-AA08; Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market Issues related to the affordability of prescription drugs and competitive marketplace, including: pedigree, manufacturer market and data exclusivity, REMS, accelerated generic approval, biosimilars H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1264/S.801: Payment Commission Data Act H.R.965/S.340: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act H.R.2376/S.1227: Prescription Pricing for the People Act H.R.1035: Prescription Drug Price Transparency Act H.R.938: Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act H.R.985: Fair Access for Safe and Timely (FAST) Generics Act H.R.1499: Protecting Consumer Access to Generic Drugs Act H.R.1520: Purple Book Continuity Act H.R.1503: Orange Book Transparency Act H.R.1781: Payment Commission Data Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act H.R.3: Lower Drug Costs Now Act S.476: C-THRU Act S.64: Preserve Access to Affordable Generics and Biosimilars Act S.659: Biologic Patent Transparency Act S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act S.1895: Lower Health Care Costs Act S.2543: Prescription Drug Pricing Reduction Act S.2247: Phair Relief Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits Issues included in the Administrations drug pricing Blueprint Issues related to HHS OIG Proposed Rule 42 CFR Part 1001 RIN 0936-AA08; Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees Issues related to CMS Proposed Rule 42 CFR Parts 422 and 423 RIN 0938-AT92; Modernizing Part D and Medicare Advantage To Lower Out-of-Pocket Expenses H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1264/S.801: Payment Commission Data Act S.476: C-THRU Act H.R.1035: Prescription Drug Price Transparency Act H.R.1781 Payment Commission Data Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act
Issues related to prescription drug coverage and pharmacy benefits Issues included in the Administrations drug pricing Blueprint Issues related to HHS OIG Proposed Rule 42 CFR Part 1001 RIN 0936-AA08; Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees Issues related to CMS Proposed Rule 42 CFR Parts 422 and 423 RIN 0938-AT92; Modernizing Part D and Medicare Advantage To Lower Out-of-Pocket Expenses Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market Issues related to the affordability of prescription drugs and competitive marketplace, including: pedigree, manufacturer market and data exclusivity, REMS, accelerated generic approval, biosimilars H.R.803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act H.R.1034/S.640: Phair Pricing Act of 2019 H.R.1264/S.801: Payment Commission Data Act H.R.965/S.340: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act H.R.2376/S.1227: Prescription Pricing for the People Act S.476: C-THRU Act S.64: Preserve Access to Affordable Generics and Biosimilars Act S.659: Biologic Patent Transparency Act S.657: Drug Price Transparency Act S.977: Transparent Drug Pricing Act S.1895: Lower Health Care Costs Act H.R.1035: Prescription Drug Price Transparency Act H.R.938: Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act H.R.985: Fair Access for Safe and Timely (FAST) Generics Act H.R.1499: Protecting Consumer Access to Generic Drugs Act H.R.1520: Purple Book Continuity Act H.R.1503: Orange Book Transparency Act H.R.1781 Payment Commission Data Act H.R.2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting Act H.R.2115: Public Disclosure of Drug Discounts Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks. Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy. Issues related to HHS OIG Proposed Rule 42 CFR Part 1001 RIN 0936-AA08; Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Proposed Rule 42 CFR Parts 422 and 423 RIN 0938-AT92; Modernizing Part D and Medicare Advantage To Lower Out-of-Pocket Expenses. H.R. 803/S.988: Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R.1034/S.640: Phair Pricing Act of 2019. H.R.1035: Prescription Drug Price Transparency Act. S. 476: C-THRU Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE